Onkologie. 2008:2(4):223-224

ONCOLOGY TREATMENT OF LIVER TUMORS

Jindřich Fínek
Chirurgická klinika FN Plzeň

Hepatocellular carcinoma is the seventh most common malignancy in the world, the causes of mortality among cancer is in third place. Treatment consists of surgical resection or liver transplant. Non-surgical treatment options are limited, a new chance to bring the use of biological medicines.

Keywords: Key words: liver tumor, biological treatment, liver resection, liver transplantation.

Published: December 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fínek J. ONCOLOGY TREATMENT OF LIVER TUMORS. Onkologie. 2008;2(4):223-224.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Llovet JM, Ricci S, Mazzaferro V. Sorafenib in advanced hepatocellular carcinoma, N Engl J Med, 2008; Jul 24 359(4): 420-422. Go to original source... Go to PubMed...
    2. Siegel AB, Cohen EI, Ocean A, et al. Phase II Trial Evaluating The Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma. J Clin Oncol 2008; 26: 2992-2998. Go to original source... Go to PubMed...
    3. Makuuchi M, Sano K, The surgical approach to HCC: our progress and results in Japan. Liver transpl 2004; 10: 46-52. Go to original source... Go to PubMed...
    4. Pawlik TM, Scoggins CR, Thomas MB, et al Advances in the surgical management of liver malignancies. Cancer J 2004; 10: 74-87. Go to original source... Go to PubMed...
    5. Madoff DC, Hicks ME, Abdalia EK, at al. Portal vein embolisation with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness - study in 26 patients. Radiology 2003; 227: 251-260. Go to original source... Go to PubMed...
    6. Farges O, Belghiti J, Klanmanesh, at al. Portal vein embolisation before right hepatectomy, prospective clinical trial, Ann Surg 2003; 237: 208-217. Go to original source... Go to PubMed...
    7. Yao Fy, Ferrell L, Bass NM, at al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403. Go to original source... Go to PubMed...
    8. NCCN, Practice Guidelines in Oncology - v. 2. 2008, Hepatobiliary Cancers, www.nccn.org.
    9. Zásady cytostatické léčby maligních onkologických onemocnění, Česká onkologická společnost, 2008.

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.